PEX11α is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation

Molecular and Cellular Biology

Volumn 22, Issue 23, 2002, Pages 8226-8240

  Li, Xiaoling ^a   Baumgart, Eveline ^a   Dong, Gao Xiang ^a   Morrell, James C ^a   Jimenez Sanchez, Gerardo ^a   Valle, David ^a   Smith, Kirby D ^a   Gould, Stephen J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; MEMBRANE PROTEIN; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN PEX11 ALPHA; UNCLASSIFIED DRUG; 4-PHENYLBUTYRIC ACID; ANTINEOPLASTIC AGENT; ARYLBUTYRIC ACID DERIVATIVE; CELL RECEPTOR; FATTY ACID; PEX11ALPHA PROTEIN, MOUSE; PEX11B PROTEIN, MOUSE; PEX11C PROTEIN, MOUSE; PEX11G PROTEIN, HUMAN; PLASMALOGEN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL ORGANELLE; CELL PROLIFERATION; CONTROLLED STUDY; EUKARYOTE; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC CODE; MAMMALIAN GENETICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DIET; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; LIVER; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; MOUSE MUTANT; MOUSE STRAIN; OXIDATION REDUCTION REACTION; PEROXISOME; PHYLOGENY; SEQUENCE ALIGNMENT; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; DIET; FATTY ACIDS; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE TARGETING; LIVER; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEROXISOME PROLIFERATORS; PEROXISOMES; PHENOTYPE; PHENYLBUTYRATES; PHYLOGENY; PLASMALOGENS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEQUENCE ALIGNMENT; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS;

EID: 0036882106     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.23.8226-8240.2002     Document Type: Article

References (53)

1. Abe, I., and Y. Fujiki. 1998. cDNA cloning and characterization of a constitutively expressed isoform of the human peroxin Pex11p. Biochem. Biophys. Res. Commun. 252:529-533.
2. Abe, I., K. Okumoto, S. Tamura, and Y. Fujiki. 1998. Clofibrate-inducible, 28-kDa peroxisomal integral membrane protein is encoded by PEX11. FEBS Lett. 431:468-472.
3. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
4. Bellu, A. R., M. Komori, I. J. van der Klei, J. A. Kiel, and M. Veenhuis. 2001. Peroxisome biogenesis and selective degradation converge at Pex14p. J. Biol. Chem. 276:44570-44574.
5. Berger, J., and D. E. Moller. 2002. The mechanisms of action of PPARs. Annu. Rev. Med. 53:409-435.
6. Chang, C. C., W. H. Lee, H. W. Moser, D. Valle, and S. J. Gould. 1997. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Nat. Genet. 15:385-388.
7. Chang, C. C., S. South, D. Warren, J. Jones, A. B. Moser, H. W. Moser, and S. J. Gould. 1999. Metabolic control of peroxisome abundance. J. Cell Sci. 112:1579-1590.
8. Chang, K. T., and K. T. Min. 2002. Regulation of lifespan by histone deacetylase. Ageing Res. Rev. 1:313-326.
9. Erdmann, R., and G. Blobel. 1995. Giant peroxisomes in oleic acid-induced Saccharomyces cerevisiae lacking the peroxisomal membrane protein Pmp27p. J. Cell Biol. 128:509-523.
10. Evan, G. E., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
11. Fahimi, H. D. 1969. Cytochemical localization of peroxidatic activity of catalase in rat hepatic microbodies (peroxisomes). J. Cell Biol. 43:275-288.
12. Gould, S. G., D. Valle, and G. V. Raymond. 2001. The peroxisome biogenesis disorders, p. 3181-3217. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The Metabolic and Molecular Bases of Inherited Disease, 8th Ed., vol. 2. McGraw-Hill, New York, N.Y.
13. Hoepfner, D., M. van den Berg, P. Philippsen, H. F. Tabak, and E. H. Hettema. 2001. A role for Vps1p, actin, and the Myo2p motor in peroxisome abundance and inheritance in Saccharomyces cerevisiae. J. Cell Biol. 155:979-990.
14. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the Mouse Embryo: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Imoto, M., I. Tachibana, and R. Urrutia. 1998. Identification and functional characterization of a novel human protein highly related to the yeast dynamin-like GTPase Vps1p. J. Cell Sci. 111:1341-1349.
16. Kamimoto, T., Y. Nagai, H. Onogi, Y. Muro, T. Wakabayashi, and M. Hagiwara. 1998. Dymple, a novel dynamin-like high molecular weight GT-Pase lacking a proline-rich carboxyl-terminal domain in mammalian cells. J. Biol. Chem. 273:1044-1051.
17. Kang, H. L., S. Benzer, and K. T. Min. 2002. Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. USA 99:838-843.
18. Karpichev, I. V., and G. M. Small. 1998. Global regulatory functions of Oaf1p and Pip2p (Oaf2p), transcription factors that regulate genes encoding peroxisomal proteins in Saccharomyces cerevisiae. Mol. Cell. Biol. 18:6560-6570.
19. Kaufmann, W. E., C. Theda, S. Naidu, P. A. Watkins, A. B. Moser, and H. W. Moser. 1996. Neuronal migration abnormality in peroxisomal bifunctional enzyme defect. Ann. Neurol. 39:268-271.
20. Kim, J., and D. J. Klionsky. 2000. Autophagy, cytoplasm -to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. Annu. Rev. Biochem. 69:303-342.
21. Kirchhausen, T. 2000. Three ways to make a vesicle. Nat. Rev. Mol. Cell Biol. 1:187-198.
22. Li, X., E. Baumgart, J. C. Morrell, G. Jimenez-Sanchez, D. Valle, and S. G. Gould. 2002. PEX11β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol. Cell. Biol. 22:4358-4365.
23. Li, X., and S. G. Gould. 2002. PEX11 promotes peroxisome division independently of peroxisome metabolism. J. Cell Biol. 156:643-651.
24. Lorenz, P., A. G. Maier, E. Baumgart, R. Erdmann, and C. Clayton. 1998. Elongation and clustering of glycosomes in Trypanosoma brucei overexpressing the glycosomal Pex11p. EMBO J. 17:3542-3555.
25. Maier, A., P. Lorenz, F. Voncken, and C. Clayton. 2001. An essential dimeric membrane protein of trypanosome glycosomes. Mol. Microbiol. 39:1443-1451.
26. Maier, A. G., S. Schulreich, M. Bremser, and C. Clayton. 2000. Binding of coatomer by the PEX11 C-terminus is not required for function. FEBS Lett. 484:82-86.
27. Marshall, P., Y. Krimkevich, R. Lark, J. Dyer, M. Veenhuis, and J. Goodman. 1995. Pmp27 promotes peroxisomal proliferation. J. Cell Biol. 129:345-355.
28. McGuinness, M. C., H. P. Zhang, and K. D. Smith. 2001. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. Mol. Genet. Metab. 74:256-263.
29. Moser, A. B., N. Kreiter, L. Bezman, S. Lu, G. V. Raymond, S. Naidu, and H. W. Moser. 1999. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45:100-110.
30. Moser, H. W. 1999. Genotype-phenotype correlations in disorders of peroxisome biogenesis. Mol. Genet. Metab. 68:316-327.
31. Passreiter, M., M. Anton, D. Lay, R. Frank, C. Harter, F. T. Wieland, K. Gorgas, and W. W. Just. 1998. Peroxisome biogenesis: Involvement of ARF and coatomer. J. Cell Biol. 141:373-383.
32. Reddy, J. K., and T. Hashimoto. 2001. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: An adaptive metabolic system. Annu. Rev. Nutr. 21:193-230.
33. Roscher, A., B. Molzer, H. Bernheimer, S. Stockler, I. Mutz, and F. Paltauf. 1985. The cerebrohepatorenal (Zellweger) syndrome: An improved method for the biochemical diagnosis and its potential value for prenatal detection. Pediatr. Res. 19:930-933.
34. Rottensteiner, H., A. J. Kal, B. Hamilton, H. Ruis, and H. F. Tabak. 1997. A heterodimer of the Zn2Cys6 transcription factors Pip2p and Oaf1p controls induction of genes encoding peroxisomal proteins in Saccharomyces cerevisiae. Eur. J. Biochem. 247:776-783.
35. Sacksteder, K. A., and S. J. Gould. 2000. The genetics of peroxisome biogenesis. Annu. Rev. Genet. 34:623-652.
36. Sakai, Y., P. A. Marshall, A. Saiganji, K. Takabe, H. Saiki, N. Kato, and J. M. Goodman. 1995. The Candida boidinii peroxisomal membrane protein Pmp30 has a role in peroxisomal proliferation and is functionally homologous to Pmp27 from Saccharomyces cerevisiae. J. Bacteriol. 177:6773-6781.
37. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
38. Schrader, M., B. E. Reuber, J. C. Morrell, G. Jimenez-Sanchez, C. Obie, T. Stroh, D. Valle, T. A. Schroer, and S. J. Gould. 1998. Expression of PEX11β mediates peroxisome proliferation in the absence of extracellular stimuli. J. Biol. Chem. 273:29607-29614.
39. Slawecki, M., G. Dodt, S. Steinberg, A. B. Moser, H. W. Moser, and S. J. Gould. 1995. Identification of three distinct peroxisomal protein import defects in patients with peroxisomal biogenesis disorders. J. Cell Sci. 108:1817-1829.
40. South, S. T., and S. J. Gould. 1999. Peroxisome synthesis in the absence of pre-existing peroxisomes. J. Cell Biol. 144:255-266.
41. South, S. T., K. A. Sacksteder, X. Li, Y. Liu, and S. J. Gould. 2000. Inhibitors of COPI and COPII do not block PEX3-mediated peroxisome synthesis. J. Cell Biol. 149:1345-1360.
42. Subramani, S. 1998. Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. Physiol. Rev. 78:171-188.
43. van Roermund, C. W., H. F. Tabak, M. van Den Berg, R. J. Wanders, and E. H. Hettema. 2000. Pex11p plays a primary role in medium-chain fatty acid oxidation, a process that affects peroxisome number and size in Saccharomyces cerevisiae. J. Cell Biol. 150:489-498.
44. Voorn-Brouwer, T., A. Kragt, H. F. Tabak, and B. Distel. 2001. Peroxisomal membrane proteins are properly targeted to peroxisomes in the absence of COPI- and COPII-mediated vesicular transport. J. Cell Sci. 114:2199-2204.
45. Wanders, R. J., and J. M. Tager. 1998. Lipid metabolism in peroxisomes in relation to human disease. Mol. Aspects Med. 19:69-154.
46. Wanders, R. J., P. Vreken, S. Ferdinandusse, G. A. Jansen, H. R. Waterham, C. W. van Roermund, and E. G. Van Grunsven. 2001. Peroxisomal fatty acid alpha- and beta-oxidation in humans: Enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem. Soc. Trans. 29:250-267.
47. Wanders, R. J. A., P. G. Barth, and H. S. A. Heymans. 2001. Single peroxisomal enzyme deficiencies, p. 3219-3256. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The Metabolic and Molecular Bases of Inherited Disease, 8th Ed., vol. 2. McGraw-Hill, New York, N.Y.
48. Wanders, R. J. A., C. Jakobs, and O. H. Skejldal. 2001. Refsum disease, p. 3303-3322. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The Metabolic and Molecular Bases of Inherited Disease, 8th Ed., vol. 2. McGraw-Hill, New York, N.Y.
49. Wang, T., A. M. Lawler, G. Steel, and D. Valle. 1995. Paradoxical hypoornithenemia and neonatal lethality in mice with targeted disruption of the OAT gene. Nat. Genet. 11:185-190.
50. Watkins, P., E. J. Ferrell, J. Pedersen, and G. Hoefler. 1991. Peroxisomal fatty acid β-oxidation in HepG2 cells. Arch. Biochem. Biophys. 289:329-366.
51. Wei, H., S. Kemp, M. C. McGuinness, A. B. Moser, and K. D. Smith. 2000. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders. Ann. Neurol. 47:286-296.
52. Yahraus, T., N. Braverman, G. Dodt, J. E. Kalish, J. C. Morrell, H. W. Moser, D. Valle, and S. J. Gould. 1996. The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J. 15:2914-2923.
53. Zenger-Hain, J., D. A. Craft, and W. B. Rizzo. 1992. Diagnosis of inborn errors of phytanic acid oxidation using tritiated phytanic acid. Prog. Clin. Biol. Res. 375:399-407.